Literature DB >> 13163327

Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.

A B SABIN, W A HENNESSEN, J WINSSER.   

Abstract

Attempts were made to "convert" highly virulent strains of the 3 immunologic types of poliomyelitis virus (Mahoney, Y-SK, and Leon) into avirulent variants. Tests involving intracerebral, intramuscular, or oral administration of virus to cynomolgus monkeys indicated that mere propagation in cultures of kidney tissue of cynomolgus monkeys had no effect on virulence when single or small numbers of virus particles were used as seed, and harvests were delayed for 24 hours or more after the appearance of cytopathogenic change. On the other hand, passages at 24 hour intervals with large inocula (10(5) to 10(6) TCD(60)) produced culture fluids with diminished virulence and unusual patterns of response in cynomolgus monkeys. Purification of such culture fluids by the terminal dilution technique yielded modified strains which proved to be avirulent after administration by the intracerebral, intramuscular, or oral routes in cynomolgus monkeys. Neither paralysis nor CNS lesions were found in any of more than 80 monkeys inoculated intracerebrally with various amounts of virus. However, focal neuronal lesions were found in the spinal cord of 3 of 48 monkeys inoculated intramuscularly with various amounts of the Mahoney variant, in 2 of 20 receiving the Y-SK variant, though in none of 40 inoculated with various amounts of the Leon variant. Virus recovered from the spinal cord of one of the monkeys in the Mahoney group produced no paralysis on intracerebral passage in monkeys. It is assumed that all 3 modified viruses possess a limited capacity to affect lower motor neurones of cynomolgus monkeys when these are directly exposed to them by accidental intraneural or traumatic intracerebral injection. On propagation in cynomolgus kidney cultures the modified viruses reached titers of approximately 10(7) TCD(50) per ml., as measured by cytopathogenic activity on renal epithelial cells in vitro, yet produced no perceptible pathologic changes in the muscles, kidneys, testes, ovaries, heart, pancreas, adrenals, liver, or spleen of cynomolgus monkeys inoculated intramuscularly. The modified viruses were immunogenic after intramuscular injection, but a large proportion of cynomolgus monkeys failed to develop antibody after small doses, indicating that in this host the experimentally produced variants multiplied less readily in non-nervous tissue than the virulent parent strains. Tests with the Type 1 virus showed that the orally administered avirulent variant can induce the formation of antibody and bring about resistance to the occurrence of paralysis such as results from ingestion of the virulent, parent strain. The Types 1 and 2 modified viruses are paralytogenic in mice after direct spinal inoculation whereas the Type 3 virus is not. The Type 1 virus became paralytogenic for mice when it lost its virulence for cynomolgus monkeys by the indicated routes. The Type 2 virus lost its virulence for mice by the intracerebral but not intraspinal routes when it was still fully virulent for cynomolgus monkeys, and retained its paralytogenic activity in intraspinally inoculated mice after it had lost its virulence for cynomolgus monkeys by the indicated routes. The parent Type 3 virus was paralytogenic in intraspinally inoculated mice when it was still fully virulent for cynomolgus monkeys, but this property disappeared in the modified virus when it became avirulent for monkeys.

Entities:  

Keywords:  POLIOMYELITIS VIRUS

Mesh:

Year:  1954        PMID: 13163327      PMCID: PMC2136347          DOI: 10.1084/jem.99.6.551

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Present status and future possibilities of a vaccine for the control of poliomyelitis.

Authors:  A B SABIN
Journal:  AMA Am J Dis Child       Date:  1953-09

2.  Adaptation of type I poliomyelitis virus to mice.

Authors:  C P LI; M SCHAEFFER
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

3.  Incomplete growth cycle of influenza virus in mouse brain.

Authors:  R W SCHLESINGER
Journal:  Proc Soc Exp Biol Med       Date:  1950-07

4.  Further modification of the mouse adapted type III poliomyelitis virus.

Authors:  C P LI; M SCHAEFFER
Journal:  Proc Soc Exp Biol Med       Date:  1953 Aug-Sep

5.  Adaptation of Leon strain of poliomyelitis to mice.

Authors:  C P LI; K HABEL
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

6.  Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON
Journal:  Am J Hyg       Date:  1952-01

7.  Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice.

Authors:  D BODIAN; I M MORGAN; C E SCHWERDT
Journal:  Am J Hyg       Date:  1950-01

8.  Poliomyelitis. I. Propagation of the MEFI strain of poliomyelitis virus in the suckling hamster.

Authors:  A W MOYER; C ACCORTI; H R COX
Journal:  Proc Soc Exp Biol Med       Date:  1952-11

9.  Mechanism of production of pulmonary lesions in mice by Newcastle disease virus (NDV).

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1951-09       Impact factor: 14.307

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  38 in total

1.  [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].

Authors:  F UNTERHARNSCHEIDT; O BONIN
Journal:  Arch Psychiatr Nervenkr       Date:  1965-03-01

2.  Approach to control of poliomyelitis by immunological methods.

Authors:  T FRANCIS
Journal:  Bull N Y Acad Med       Date:  1955-04

3.  Vaccination against poliomyelitis with attenuated live virus.

Authors:  D R MACLEOD
Journal:  Can Med Assoc J       Date:  1959-06-15       Impact factor: 8.262

4.  Cell metabolism and virus.

Authors:  E KOVACS
Journal:  Experientia       Date:  1961-04-15

5.  Experimental infection of human volunteers with the U-virus-a strain of ECHO virus type 11.

Authors:  F E BUCKLAND; M L BYNOE; L PHILIPSON; D A TYRRELL
Journal:  J Hyg (Lond)       Date:  1959-09

6.  Historical aspects of the development of live virus vaccine in poliomyelitis.

Authors:  H KOPROWSKI
Journal:  Br Med J       Date:  1960-07-09

7.  [Further studies on cultivation and variants of the classical fowl plague virus in human tissue explants].

Authors:  C HALLAUER; G KRONAUER
Journal:  Arch Gesamte Virusforsch       Date:  1959

8.  Present status of poliomyelitis vaccination.

Authors:  R D DEFRIES
Journal:  Can Med Assoc J       Date:  1957-10-01       Impact factor: 8.262

9.  [Prevention of poliomyelitis; present and future].

Authors:  P LEPINE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

10.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.